Brought to you by 
Percutaneous Valve Technologies licenses Heartport's patents
07 Aug 2001
Executive Summary
Percutaneous Valve Technologies (therapeutics for cardiovascular diseases) has licensed exclusive worldwide rights to Heartport's (less invasive surgical devices) Andersen patents pertaining to treating valvular heart disease.
Deal Industry
- Medical Devices
-
Medical Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Alliance
- Includes Equity
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Percutaneous Valve Technologies licenses Heartport's patents
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice